1142 related articles for article (PubMed ID: 33173010)
1. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
[TBL] [Abstract][Full Text] [Related]
2. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; Jin W; Liu H; Sharma P; Linhardt RJ
bioRxiv; 2020 Jul; ():. PubMed ID: 32577638
[TBL] [Abstract][Full Text] [Related]
3. Marine sulfated glycans inhibit the interaction of heparin with S-protein of SARS-CoV-2 Omicron XBB variant.
He P; Song Y; Jin W; Li Y; Xia K; Kim SB; Dwivedi R; Farrag M; Bates J; Pomin VH; Wang C; Linhardt RJ; Dordick JS; Zhang F
Glycoconj J; 2024 Apr; 41(2):163-174. PubMed ID: 38642280
[TBL] [Abstract][Full Text] [Related]
4. Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein.
Tandon R; Mitra D; Sharma P; McCandless MG; Stray SJ; Bates JT; Marshall GD
Sci Rep; 2020 Nov; 10(1):19076. PubMed ID: 33154514
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
Clausen TM; Sandoval DR; Spliid CB; Pihl J; Perrett HR; Painter CD; Narayanan A; Majowicz SA; Kwong EM; McVicar RN; Thacker BE; Glass CA; Yang Z; Torres JL; Golden GJ; Bartels PL; Porell RN; Garretson AF; Laubach L; Feldman J; Yin X; Pu Y; Hauser BM; Caradonna TM; Kellman BP; Martino C; Gordts PLSM; Chanda SK; Schmidt AG; Godula K; Leibel SL; Jose J; Corbett KD; Ward AB; Carlin AF; Esko JD
Cell; 2020 Nov; 183(4):1043-1057.e15. PubMed ID: 32970989
[TBL] [Abstract][Full Text] [Related]
6. Marine Sulfated Polysaccharides as Promising Antiviral Agents: A Comprehensive Report and Modeling Study Focusing on SARS CoV-2.
Salih AEM; Thissera B; Yaseen M; Hassane ASI; El-Seedi HR; Sayed AM; Rateb ME
Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436245
[TBL] [Abstract][Full Text] [Related]
7. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
[TBL] [Abstract][Full Text] [Related]
8. Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.
Mycroft-West CJ; Su D; Pagani I; Rudd TR; Elli S; Gandhi NS; Guimond SE; Miller GJ; Meneghetti MCZ; Nader HB; Li Y; Nunes QM; Procter P; Mancini N; Clementi M; Bisio A; Forsyth NR; Ferro V; Turnbull JE; Guerrini M; Fernig DG; Vicenzi E; Yates EA; Lima MA; Skidmore MA
Thromb Haemost; 2020 Dec; 120(12):1700-1715. PubMed ID: 33368089
[TBL] [Abstract][Full Text] [Related]
9. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.
Partridge LJ; Urwin L; Nicklin MJH; James DC; Green LR; Monk PN
Cells; 2021 Jun; 10(6):. PubMed ID: 34200372
[TBL] [Abstract][Full Text] [Related]
10. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.
Kim SY; Jin W; Sood A; Montgomery DW; Grant OC; Fuster MM; Fu L; Dordick JS; Woods RJ; Zhang F; Linhardt RJ
Antiviral Res; 2020 Sep; 181():104873. PubMed ID: 32653452
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.
Rowland R; Brandariz-Nuñez A
Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876
[TBL] [Abstract][Full Text] [Related]
12. The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica.
Jin W; Zhang W; Mitra D; McCandless MG; Sharma P; Tandon R; Zhang F; Linhardt RJ
Int J Biol Macromol; 2020 Nov; 163():1649-1658. PubMed ID: 32979436
[TBL] [Abstract][Full Text] [Related]
13. Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.
Xu C; Wang A; Geng K; Honnen W; Wang X; Bruiners N; Singh S; Ferrara F; D'Angelo S; Bradbury ARM; Gennaro ML; Liu D; Pinter A; Chang TL
Viruses; 2021 May; 13(6):. PubMed ID: 34064066
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of SARS-CoV-2 wild-type (Wuhan-Hu-1) and Delta (B.1.617.2) strains by marine sulfated glycans.
Dwivedi R; Sharma P; Farrag M; Kim SB; Fassero LA; Tandon R; Pomin VH
Glycobiology; 2022 Sep; 32(10):849-854. PubMed ID: 35788318
[TBL] [Abstract][Full Text] [Related]
15. Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro.
Zhan Y; Ta W; Tang W; Hua R; Wang J; Wang C; Lu W
Drug Dev Res; 2021 Dec; 82(8):1124-1130. PubMed ID: 33847382
[TBL] [Abstract][Full Text] [Related]
16. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
17. Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor.
Kim YS; Chung HS; Noh SG; Lee B; Chung HY; Choi JG
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445310
[TBL] [Abstract][Full Text] [Related]
18. Seaweed-derived fucoidans and rhamnan sulfates serve as potent anti-SARS-CoV-2 agents with potential for prophylaxis.
Song Y; Singh A; Feroz MM; Xu S; Zhang F; Jin W; Kumar A; Azadi P; Metzger DW; Linhardt RJ; Dordick JS
Carbohydr Polym; 2024 Aug; 337():122156. PubMed ID: 38710572
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of SARS-CoV-2 Virus Entry by the Crude Polysaccharides of Seaweeds and Abalone Viscera In Vitro.
Yim SK; Kim K; Kim IH; Chun SH; Oh TH; Kim JU; Kim JW; Jung WH; Moon HS; Ku BS; Jung KJ
Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33921174
[TBL] [Abstract][Full Text] [Related]
20. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC
J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
